| OTC Markets: VASO
Vasomedical, Inc. is a medical technology company, which is engaged in the manufacturing and sale of medical devices, and in the domestic sale of diagnostic imaging products. Its core product Enhanced External Counterpulsation Therapy (EECP) system is a non-invasive treatment of cardiovascular disease. The company operates through two business segments: Equipment and Sales Representation. The Equipment segment is engaged in designing, manufacturing, marketing and supporting EECP enhanced external counterpulsation systems both domestically and internationally, as well as the marketing of other medical devices. The Sales Representation segment operates through the VasoHealthcare subsidiary and is currently engaged solely in the execution of the company's responsibilities under its agreement with GEHC. Vasomedical was founded by John C. K. Hui in July 1987 and is headquartered in Westbury, NY.